NCT06071533View on ClinicalTrials.gov

Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic Syndrome

CompletedOBSERVATIONAL
Enrollment

441

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 30, 2022

Study Completion Date

October 3, 2023

Conditions
Acute Kidney InjuryNephrotic SyndromeNephropathy
Interventions
DRUG

Dandshen

Dandshen injection 20ml /day

Trial Locations (1)

325000

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors
lead

First Affiliated Hospital of Wenzhou Medical University

OTHER

NCT06071533 - Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic Syndrome | Biotech Hunter | Biotech Hunter